Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Multiple Sclerosis, Chronic Progressive

In brief

The purpose of the study is to determine if lipoic acid can protect the brain and slow disability in secondary progressive multiple sclerosis.

Key facts

Study ID
NCT01188811
Run by
VA Office of Research and Development
People needed
54
Starts
2010-10-01
Expected to finish
2015-08-01
Last updated by the study team
2017-02-02

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.